Search research articles
Contact Us
Filters
Showing results (1-10 of 53) with videos related to
Page
of 6
Sort By:
International Journal of Molecular Sciences
|
December 11, 2022
What Exactly Is Inflammation (and What Is It Not?)
Bryan Oronsky, Scott Caroen, Tony Reid
American Journal of Cancer Research
|
May 9, 2022
The small molecule NLRP3 inhibitor RRx-001 potentiates regorafenib activity and attenuates regorafenib-induced toxicity in mice bearing human colorectal cancer xenografts
Tony Reid, Bryan Oronsky, Nacer Abrouk, et al.
International Journal of Medical Sciences
|
October 14, 2022
Superficial Venous-Associated Inflammation from Direct IV Administration of RRx-001 in Rats
Scott Caroen, Bryan Oronsky, Tony Reid, et al.
Life Sciences in Space Research
|
November 6, 2022
RRx-001 and the "Right stuff": Protection and treatment in outer space
Bryan Oronsky, Scott Caroen, Nacer Abrouk, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
November 8, 2022
Could nucleocapsid be a next-generation COVID-19 vaccine candidate - author's reply
Bryan Oronsky, Christopher Larson, Scott Caroen, et al.
Journal of Investigative Medicine High Impact Case Reports
|
March 20, 2018
A Recurrent Platinum Refractory Ovarian Cancer Patient With a Partial Response After RRx-001 Resensitization to Platinum Doublet
Hope Cottrill, Stephanie Cason, Scott Caroen, et al.
Frontiers in Oncology
|
June 21, 2023
A multicenter, phase 1, dose escalation clinical trial (G-FORCE-1) of XRT, RRx-001 and temozolomide followed by temozolomide +/- RRx-001 in newly diagnosed glioblastoma
Howard Fine, Tony Reid, Scott Caroen, et al.
Frontiers in Oncology
|
June 14, 2023
RRx-001: a chimeric triple action NLRP3 inhibitor, Nrf2 inducer, and nitric oxide superagonist
Bryan Oronsky, Lori Takahashi, Richard Gordon, et al.
Molecular Cancer Therapeutics
|
February 1, 2024
Predicting the Abscopal Phenomenon-Letter to the Editor
Anthony P Conley, Bryan Oronsky, Scott Caroen, et al.
Journal for Immunotherapy of Cancer
|
October 26, 2024
TGF-β trap of AdAPT-001 turns up the heat on tumors and turns down checkpoint blocker resistance
Tony R Reid, Bryan Oronsky, Jeannie Williams, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 53) with videos related to
Sort By:
Page
of 6
International Journal of Molecular Sciences
|
December 11, 2022
What Exactly Is Inflammation (and What Is It Not?)
Bryan Oronsky, Scott Caroen, Tony Reid
American Journal of Cancer Research
|
May 9, 2022
The small molecule NLRP3 inhibitor RRx-001 potentiates regorafenib activity and attenuates regorafenib-induced toxicity in mice bearing human colorectal cancer xenografts
Tony Reid, Bryan Oronsky, Nacer Abrouk, et al.
International Journal of Medical Sciences
|
October 14, 2022
Superficial Venous-Associated Inflammation from Direct IV Administration of RRx-001 in Rats
Scott Caroen, Bryan Oronsky, Tony Reid, et al.
Life Sciences in Space Research
|
November 6, 2022
RRx-001 and the "Right stuff": Protection and treatment in outer space
Bryan Oronsky, Scott Caroen, Nacer Abrouk, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
November 8, 2022
Could nucleocapsid be a next-generation COVID-19 vaccine candidate - author's reply
Bryan Oronsky, Christopher Larson, Scott Caroen, et al.
Journal of Investigative Medicine High Impact Case Reports
|
March 20, 2018
A Recurrent Platinum Refractory Ovarian Cancer Patient With a Partial Response After RRx-001 Resensitization to Platinum Doublet
Hope Cottrill, Stephanie Cason, Scott Caroen, et al.
Frontiers in Oncology
|
June 21, 2023
A multicenter, phase 1, dose escalation clinical trial (G-FORCE-1) of XRT, RRx-001 and temozolomide followed by temozolomide +/- RRx-001 in newly diagnosed glioblastoma
Howard Fine, Tony Reid, Scott Caroen, et al.
Frontiers in Oncology
|
June 14, 2023
RRx-001: a chimeric triple action NLRP3 inhibitor, Nrf2 inducer, and nitric oxide superagonist
Bryan Oronsky, Lori Takahashi, Richard Gordon, et al.
Molecular Cancer Therapeutics
|
February 1, 2024
Predicting the Abscopal Phenomenon-Letter to the Editor
Anthony P Conley, Bryan Oronsky, Scott Caroen, et al.
Journal for Immunotherapy of Cancer
|
October 26, 2024
TGF-β trap of AdAPT-001 turns up the heat on tumors and turns down checkpoint blocker resistance
Tony R Reid, Bryan Oronsky, Jeannie Williams, et al.
Page
of 6